Skip to main content
Clinical Trials/PACTR202401622249032
PACTR202401622249032
Completed
Phase 3

Comparative study of the safety and efficacy of levofloxacin and ciprofloxacin in the treatment of community-acquired, bacterial urinary tract infection among patients with chronic kidney disease

Dhikrullah Adebayo0 sites90 target enrollmentDecember 5, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dhikrullah Adebayo
Enrollment
90
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 5, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dhikrullah Adebayo

Eligibility Criteria

Inclusion Criteria

  • 1\.Age 18years and above.
  • 2\.Known CKD patients
  • 3\.Symptoms compatible with a diagnosis of UTI plus positive dipstick test for pyuria
  • 4\.Informed consent to participate in the study.

Exclusion Criteria

  • 1\.Patients with any rapidly progressive or terminal disease
  • 2\.Individuals with prior renal transplantation.
  • 3\.Co\-existence of other infections in addition to urinary tract infection
  • 4\.Exposure to any antimicrobial prior to presentation
  • 5\.Known previous reaction to quinolones.
  • 6\.Hospital acquired UTI
  • 7\.Catheter associated UTI

Outcomes

Primary Outcomes

Not specified

Similar Trials